Literature DB >> 20682901

Risk factors for severe Rift Valley fever infection in Kenya, 2007.

Amwayi S Anyangu1, L Hannah Gould, Shahnaaz K Sharif, Patrick M Nguku, Jared O Omolo, David Mutonga, Carol Y Rao, Edith R Lederman, David Schnabel, Janusz T Paweska, Mark Katz, Allen Hightower, M Kariuki Njenga, Daniel R Feikin, Robert F Breiman.   

Abstract

A large Rift Valley fever (RVF) outbreak occurred in Kenya from December 2006 to March 2007. We conducted a study to define risk factors associated with infection and severe disease. A total of 861 individuals from 424 households were enrolled. Two hundred and two participants (23%) had serologic evidence of acute RVF infection. Of these, 52 (26%) had severe RVF disease characterized by hemorrhagic manifestations or death. Independent risk factors for acute RVF infection were consuming or handling products from sick animals (odds ratio [OR] = 2.53, 95% confidence interval [CI] = 1.78-3.61, population attributable risk percentage [PAR%] = 19%) and being a herds person (OR 1.77, 95% CI = 1.20-2.63, PAR% = 11%). Touching an aborted animal fetus was associated with severe RVF disease (OR = 3.83, 95% CI = 1.68-9.07, PAR% = 14%). Consuming or handling products from sick animals was associated with death (OR = 3.67, 95% CI = 1.07-12.64, PAR% = 47%). Exposures related to animal contact were associated with acute RVF infection, whereas exposures to mosquitoes were not independent risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682901      PMCID: PMC2913492          DOI: 10.4269/ajtmh.2010.09-0293

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  40 in total

1.  Outbreak of Rift Valley fever--Yemen, August-October 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-12-01       Impact factor: 17.586

2.  Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Authors:  Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Sherif R Zaki; Wun-Ju Shieh; Janusz Paweska; Sylvia Omulo; Solomon Gikundi; Peter Mmbuji; Peter Bloland; Nordin Zeidner; Raphael Kalinga; Robert F Breiman; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 3.  Rift Valley fever virus.

Authors:  Ramon Flick; Michèle Bouloy
Journal:  Curr Mol Med       Date:  2005-12       Impact factor: 2.222

4.  Rift Valley fever; accidental infections among laboratory workers.

Authors:  K C SMITHBURN; A F MAHAFFY
Journal:  J Immunol       Date:  1949-06       Impact factor: 5.422

5.  Rift Valley fever outbreak--Kenya, November 2006-January 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-02-02       Impact factor: 17.586

Review 6.  Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome.

Authors:  Mohamed A Karmali
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

7.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Rift Valley fever in humans in South Africa.

Authors:  B M McIntosh; D Russell; I dos Santos; J H Gear
Journal:  S Afr Med J       Date:  1980-11-15

9.  Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies.

Authors:  Nicola Kimblin; Nathan Peters; Alain Debrabant; Nagila Secundino; Jackson Egen; Phillip Lawyer; Michael P Fay; Shaden Kamhawi; David Sacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

10.  Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

Authors:  S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

View more
  93 in total

1.  Rift Valley Fever: scientific pathways toward public health prevention and response.

Authors:  Robert F Breiman; Bruno Minjauw; S K Sharif; Peter Ithondeka; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.

Authors:  Aaron W Walters; Michael R Kujawa; Joseph R Albe; Douglas S Reed; William B Klimstra; Amy L Hartman
Journal:  Virology       Date:  2018-11-02       Impact factor: 3.616

3.  Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.

Authors:  Myrna M Miller; Kristine E Bennett; Barbara S Drolet; Robbin Lindsay; James O Mecham; Will K Reeves; Hana M Weingartl; William C Wilson
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

4.  The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice.

Authors:  S Tokuda; T Z Do Valle; L Batista; D Simon-Chazottes; L Guillemot; M Bouloy; M Flamand; X Montagutelli; J-J Panthier
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

5.  Climate Influence on Emerging Risk Areas for Rift Valley Fever Epidemics in Tanzania.

Authors:  Clement N Mweya; Leonard E G Mboera; Sharadhuli I Kimera
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

6.  Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.

Authors:  Georges Mbuyi Tshilenge; William G Dundon; Marco De Nardi; Leopold K Mulumba Mfumu; Mark Rweyemamu; Jean-Marie Kayembe-Ntumba; Justin Masumu
Journal:  Trop Anim Health Prod       Date:  2018-10-22       Impact factor: 1.559

7.  Rift Valley fever outbreak in livestock in Kenya, 2006-2007.

Authors:  Peninah Munyua; Rees M Murithi; Sherrilyn Wainwright; Jane Githinji; Allen Hightower; David Mutonga; Joseph Macharia; Peter M Ithondeka; Joseph Musaa; Robert F Breiman; Peter Bloland; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

8.  Characterization of wild-type and alternate transcription termination signals in the Rift Valley fever virus genome.

Authors:  Estelle Lara; Agnès Billecocq; Psylvia Leger; Michèle Bouloy
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 9.  Advances in Rift Valley fever research: insights for disease prevention.

Authors:  A Desiree LaBeaud; James W Kazura; Charles H King
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

10.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.